Larry Gies with iMBA students at his namesake college of business at the University of IllinoisThe MBA program of the future will be highly flexible and innovative. You can start it by taking a single course at a time for credit, or a sequence of courses that earn you a certificate in a highly sought-after … Read more
Bigger is better.When you’re young, you dream of adventures you’ll take when you’re big. In sports, you pump iron so you’re big enough to absorb punishment. Entrepreneurs scale to make themselves big enough to cash out someday. For aspiring influencers, big followings translate to authority and impact.The Wharton School of the University of Pennsylvania is … Read more
Biden Commemorates Jan. 6: ‘We, the People, Prevailed’ | National … U.S. News & World Reportsource
Your Guide to the ChargePoint Charging Network | U.S. News U.S. News & World Reportsource
How Schools Can Address Period Poverty U.S. News & World Reportsource
How U.S. High School Can Prepare International Students for College U.S. News & World Reportsource
Should Law School Hopefuls Write as Much as Allowed on … U.S. News & World Reportsource
The U.S. Stock Market: Best and Worst Performing Sectors in 2022Top Heavy: Countries by Share of the Global EconomyRanked: The 100 Biggest Public Companies in the WorldRanked: The 25 Countries Receiving the Most U.S. Immigration VisasAll of the World’s Money and Markets in One Visualization (2022)Timeline: The Most Important Science Headlines of 2022Mapped: The Most … Read more
U.S. News & World Report pledged to modify its law school rankings after a growing number of institutions, including the University of Michigan, Yale and Harvard, called the rankings “flawed.”In a letter to law school deans published on its website Monday, U.S. News & World Report said it would make a series of changes to … Read more
Drug works with the body’s immune system to clear amyloid protein buildup from the brainThe US Food and Drug Administration (FDA) has approved Lecanemab, a breakthrough drug to treat Alzheimer’s, that is manufactured by biotechnology companies Biogen and Eisai.The drug is an intravenously administered humanized monoclonal antibody that targets amyloid, the toxic protein in the … Read more